Lv3
390 积分 2024-06-09 加入
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
2个月前
已完结
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial
3个月前
已完结
Hematopoietic cell transplantation in Fanconi anemia and dyskeratosis congenita
7个月前
已完结
Fanconi Anemia Signaling and Cancer
7个月前
已完结
Fanconi anemia: current insights regarding epidemiology, cancer, and DNA repair
7个月前
已完结
Long-term outcome in patients with Fanconi anemia who received hematopoietic stem cell transplantation: a retrospective nationwide analysis
8个月前
已完结
Long-term outcome in patients with Fanconi anemia who received hematopoietic stem cell transplantation: a retrospective nationwide analysis
8个月前
已完结
Fanconi anemia: realizing hematopoietic cure
8个月前
已完结
Diagnosis and Treatment of Chronic Lymphocytic Leukemia
8个月前
已完结
CAR T Cells and T-Cell Therapies for Cancer
8个月前
已完结
皖公网安备34019202002308
